6640--Sources Sought BIOCARTIS US QC Reagents Brand Name Only

DISCLAIMER

THIS NOTICE IS FOR PLANNING PURPOSES ONLY. THE GOVERNMENT DOES NOT INTEND TO AWARD A CONTRACT ON THE BASIS OF THIS RFI OR REIMBURSE ANY COSTS ASSOCIATED WITH THE PREPARATION OF RESPONSES TO THIS RFI.

This RFI is issued solely for information and planning purposes and does not constitute a Solicitation, an Invitation for Bids, a Request for Proposal (RFP), a Request for Quotation (RFQ), or an indication the Government will contract for the items contained in this announcement. All information received in response to this RFI marked Proprietary will be handled accordingly. Responses to the RFI will not be returned. In accordance with FAR 15.201(e), responses to this RFI are not offers and cannot be accepted by the Government to form a binding contract.

PURPOSE

The purpose of this RFI is to conduct market research to find qualified vendors and to assist Network Contracting Office (NCO) 6 in determining if a future contract effort can be competitively awarded for a Set-Aside. The applicable North American Industrial Classification System (NAICS) code assigned to this effort is 339113 Surgical Appliance and Supplies Manufacturing the Small Business Size Standard of 750 employees. If the Government determines there are qualified vendors this requirement, a solicitation will be published and posted on the Contracting Opportunities website. The Government will use this information solely to determine the appropriate acquisition strategy for this procurement.Â

INTRODUCTION

The Asheville VAMC has a requirement for the annual purchase of the BioCartis Idylla Assay Kit. The BioCartis Idylla Assay Kit is the only product that can be used with the existing BioCartis Analyzer at Asheville VA Medical Center.

REQUIREMENTS

NOTE: The VHA Network Contracting Office 6 (NCO 6) is conducting a market survey to find qualified vendors who can provide the following item(s) for the Charles George, Asheville VA Medical Center, 1100 Tunnel Road, Asheville, NC 28805:

Manufacturer: BIOCARTIS US Inc.

Item Number

Description

Unit

1

BRAF Assay A0011/6

12 PG

2

KRAS Assay A0021/6

22 PG

3

EGFR Assay A0061/6

16 PG

4

NRAS3 Assay A0031/6

6 PG

5

MSI Assay A0101/6

13 PG

8

GeneFusion Assay A0121/6

6 PG

DESCRIPTION OF INFORMATION REQUESTED

Vendors with a GSA schedule shall provide the contract number of that schedule and the expiration date as well as product NAICS codes. All items should be clearly identified if they are scheduled items or open market items.

HOW TO RESPOND:

All responses shall be submitted no later than 3:00 PM EDT Monday, September 18, 2023. All interested parties should respond, in writing via email to james.risbonva.gov. No telephone inquiries will be accepted. Respondents to this RFI shall provide the following information:

Company/individual name,

Address,

Point of contact with phone number

Information describing your interest,

Indicate FSS/GSA contract number or Open Market, as applicable

FSS Category you qualify for

UEI Number

Tax ID number

DUNS number

Capabilities statement

Company Socio-Economic SIZE (example large, small, SDVOSB, VOSB, WOSB etc.)

Authorized Distributor Letter

Interested firms are reminded that in accordance with FAR 4.1201(a) Prospective contractors shall complete electronic annual representations and certifications at the System for Award Management (SAM) as a part of required registration in conjunction with FAR 4.1102(a) that states, Prospective contractors shall be registered in the (SAM) database prior to award of a contract or agreement. Therefore, due to time constraints, vendors must be registered in System for Award Management (SAM) under the above NAICS code at http://www.sam.gov to be considered for an award.

Please submit responses via email in Microsoft Office format by 3:00 PM (Eastern Time) 09/18/2023. Please include RFI # 36C24624Q0011 in subject title.

NOTE: Responses to this announcement will not be returned, nor will there be any ensuing discussions or debriefings of any responses. However, information obtained as a result of this announcement may be reflected in any subsequent solicitation. This announcement is Government market research purposes ONLY.